Cover Image

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Teresa T. Ho, D. Max Smith, Christina L. Aquilante, Emily J. Cicali, Nihal El Rouby, Daniel L. Hertz, Iman Imanirad, Jai N. Patel, Stuart A. Scott, Sandra M. Swain, Sony Tuteja, J. Kevin Hicks
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test
by: James M. Stevenson, et al.
Published: (2025)

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges
by: D. Max Smith, et al.
Published: (2025)

Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy
by: Nihal El Rouby, et al.
Published: (2025)

Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module
by: Bradley T. Hall, et al.
Published: (2025)

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
by: Michael T. Eadon, et al.
Published: (2025)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
by: Katherine M. Robinson, et al.
Published: (2024)

Use ofCYP2D6Inhibitors withCYP2D6Opioids: Association with Emergency Department Visits for Pain
by: Noor Ahmed Nahid, et al.
Published: (2024)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update
by: Maud Maillard, et al.
Published: (2026)

GenoStaR : An R Package for Genotype to Star Allele Conversion for Major Cytochrome P450 Family of Genes
by: Alex J. Coulter, et al.
Published: (2025)

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program
by: Catherine Chanfreau‐Coffinier, et al.
Published: (2025)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
by: Matthijs W. van Hoogdalem, et al.
Published: (2025)

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans
by: Guang Yang, et al.
Published: (2025)

Editorial: Peroxisome Proliferator‐Activated Receptor Agonists—Shifting the Goalpost From Biochemical Response to Symptom Directed Therapy in PBC
by: Henry H. Nguyen, et al.
Published: (2026)

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy
by: Julio D. Duarte, et al.
Published: (2024)

Editorial: Time to Genotype—Genetic Risk and Prognosis in Steatotic Liver Disease
by: Rosellina M. Mancina, et al.
Published: (2025)

Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply
by: Daniel Q. Huang, et al.
Published: (2026)

Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data
by: Kaisa Litonius, et al.
Published: (2024)

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
by: Kenza Abouir, et al.
Published: (2024)

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study
by: Henk‐Jan Guchelaar, et al.
Published: (2025)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply
by: Stuart McPherson, et al.
Published: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
by: Stuart McPherson, et al.
Published: (2024)

CYP2C19 Genotype is Associated with Citalopram Treatment Outcomes in a Real‐World Setting
by: Yoomi Park, et al.
Published: (2026)

Editorial: Understanding the Role of the Alpha‐1 Pi* MZ Genotype in the Development of Hepatocellular Carcinoma for Patients With ACLD
by: Kaitlyn Carlson, et al.
Published: (2026)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
by: Liang Zhao, et al.
Published: (2024)

PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study
by: Daniel Q. Huang, et al.
Published: (2026)

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation
by: Hyun Woong Park, et al.
Published: (2025)

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
by: Danwei Shao, et al.
Published: (2026)

In Memoriam Arthur J. Atkinson, Jr. (1938–2024)
by: Juan J. L. Lertora, et al.
Published: (2024)

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects
by: Emma C. Bernsen, et al.
Published: (2025)

Analysis of US Marketed Artemisinin Supplements for Use in Dogs
by: Alyssa R. Berman, et al.
Published: (2024)

Response to Correspondence on ‘Analysis of US Marketed Artemisinin Supplements for Use in Dogs’
by: Alyssa R. Berman, et al.
Published: (2024)

Editorial: Targeting Urgency in IBD —A Historical Divide. Authors' Reply
by: Parul Tandon, et al.
Published: (2025)

Clinical Trial: Hepatitis B Virus Genotype and a Combination of End‐of‐Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation
by: Arno Furquim d’Almeida, et al.
Published: (2025)

Impact of CYP2C19 Genotype on Sertraline and Escitalopram Exposure and Antidepressant Switching Rate: A Retrospective Cohort Study of Chinese Han Patients
by: Yuhang Yan, et al.
Published: (2025)

Editorial: Statin Therapy in Cirrhosis: More Than Just Lipid‐Lowering
by: Emily Stephenson, et al.
Published: (2026)

Editorial: Silent But Detectable—High‐Throughput Proteomics to Identify Clinically Significant Liver Disease
by: Emily Stephenson, et al.
Published: (2026)

Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
by: Anu Patel, et al.
Published: (2024)

Impact of Drug Recalls on Patients in The Netherlands: A 5‐Year Retrospective Data Analysis
by: Pieter A. Annema, et al.
Published: (2024)

Systematic Review: Incidence of Liver‐Related Events in People Living With Hepatitis Delta Virus
by: Laura E. Telep, et al.
Published: (2025)

Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review
by: Bonginkosi S'fiso Ndzamba, et al.
Published: (2024)